Cell Therapy Regulatory Toolkit: an Online Regulatory Resource
Emily J Culme-Seymour(GlaxoSmithKline (United Kingdom)), Chris Mason(Oak Ridge National Laboratory), J. Mason(Kingston University), James Lawford Davies(HESAM Université), Julian Hitchcock, Melissa K. Carpenter(Menlo School)
Cited by 5
Related Papers
Clonally Derived Human Embryonic Stem Cell Lines Maintain Pluripotency and Proliferative Potential for Prolonged Periods of Culture
|Developmental Biology|2000|1.5k
A Brief Definition of Regenerative Medicine
|Regenerative Medicine|2007|795
Differences between human and mouse embryonic stem cells
|Developmental Biology|2004|715
BTRFS
|ACM Transactions on Storage|2013|381
Lancet Commission: Stem cells and regenerative medicine
|The Lancet|2017|276